Cannara Biotech Reports Strong Growth Amidst Market Positioning Adjustments
Cannara Biotech, Inc. has recently experienced a change in its evaluation, reflecting shifts in financial metrics and market positioning. The company reported a valuation grade of very attractive, with strong cash flow and significant net profit growth, despite a negative return on equity. Its stock performance has notably outpaced broader market indices.
Cannara Biotech, Inc., a small-cap player in the Other Agricultural Products sector, has recently undergone an adjustment in evaluation. This revision reflects notable shifts in its financial metrics and market positioning. The company has reported a valuation grade classified as "very attractive," indicating a favorable assessment relative to its peers.Key financial indicators reveal a Price to Book Value of 1.58, suggesting a reasonable valuation in comparison to its assets. The company’s operating cash flow reached a peak of CAD 16.8 million, highlighting its ability to generate cash effectively. Additionally, Cannara Biotech has demonstrated a significant growth in net profit of 24.97%, with net sales for the quarter hitting CAD 27.33 million.
Despite a return on equity (ROE) of -10.12%, the stock has shown a remarkable return of 168.75% over the past year, significantly outpacing the S&P/TSX 60's return of 21.89%. These metrics contribute to the overall assessment of Cannara Biotech, Inc. as it navigates its market landscape.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Most Read
